The Combination of Metformin and Disulfiram-Cu for Effective Radiosensitization on Glioblastoma Cells

OBJECTIVE: Glioblastoma (GBM) is one of the devastating types of primary brain tumors with a negligible response to standard therapy. Repurposing drugs, such as disulfiram (DSF) and metformin (Met) have shown antitumor properties in different cell lines, including GBM. In the present study, we focus...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei, Narges, Neshasteh-Riz, Ali, Mazaheri, Zohreh, Koosha, Fereshteh, Hoormand, Mahmood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947006/
https://www.ncbi.nlm.nih.gov/pubmed/31863651
http://dx.doi.org/10.22074/cellj.2020.6798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947006/
https://www.ncbi.nlm.nih.gov/pubmed/31863651
http://dx.doi.org/10.22074/cellj.2020.6798

Ejemplares similares